NO20010553L - Krystallinske former av osanetant - Google Patents

Krystallinske former av osanetant

Info

Publication number
NO20010553L
NO20010553L NO20010553A NO20010553A NO20010553L NO 20010553 L NO20010553 L NO 20010553L NO 20010553 A NO20010553 A NO 20010553A NO 20010553 A NO20010553 A NO 20010553A NO 20010553 L NO20010553 L NO 20010553L
Authority
NO
Norway
Prior art keywords
osanetant
crystalline forms
crystalline
forms
Prior art date
Application number
NO20010553A
Other languages
English (en)
Other versions
NO20010553D0 (no
NO320645B1 (no
Inventor
Alain Alcade
Gilles Anne-Archard
Patrick Grosclaude
Olivier Monnier
Jerome Roche
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20010553D0 publication Critical patent/NO20010553D0/no
Publication of NO20010553L publication Critical patent/NO20010553L/no
Publication of NO320645B1 publication Critical patent/NO320645B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20010553A 1998-08-05 2001-02-01 Fremgangsmate for krystallisering av osanetant, krystallinske former av osanetant, og farmasoytiske preparater omfattende slike. NO320645B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810107A FR2782082B3 (fr) 1998-08-05 1998-08-05 Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
PCT/FR1999/001914 WO2000007987A1 (fr) 1998-08-05 1999-08-03 Formes cristallines du osanetant

Publications (3)

Publication Number Publication Date
NO20010553D0 NO20010553D0 (no) 2001-02-01
NO20010553L true NO20010553L (no) 2001-04-05
NO320645B1 NO320645B1 (no) 2006-01-09

Family

ID=9529458

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010553A NO320645B1 (no) 1998-08-05 2001-02-01 Fremgangsmate for krystallisering av osanetant, krystallinske former av osanetant, og farmasoytiske preparater omfattende slike.

Country Status (32)

Country Link
US (1) US7041679B2 (no)
EP (1) EP1102747B1 (no)
JP (1) JP3807938B2 (no)
KR (1) KR100571944B1 (no)
CN (1) CN1114592C (no)
AR (1) AR019953A1 (no)
AT (1) ATE243197T1 (no)
AU (1) AU748177B2 (no)
BR (1) BR9913357A (no)
CA (1) CA2339007A1 (no)
CO (1) CO5070576A1 (no)
DE (1) DE69908951T2 (no)
DK (1) DK1102747T3 (no)
DZ (1) DZ3074A1 (no)
EA (1) EA003205B1 (no)
EE (1) EE04274B1 (no)
ES (1) ES2200535T3 (no)
FR (1) FR2782082B3 (no)
HK (1) HK1035535A1 (no)
HU (1) HUP0103134A3 (no)
IS (1) IS5821A (no)
MY (1) MY121447A (no)
NO (1) NO320645B1 (no)
NZ (1) NZ509561A (no)
PL (1) PL345999A1 (no)
PT (1) PT1102747E (no)
SK (1) SK1742001A3 (no)
TR (1) TR200100261T2 (no)
TW (1) TW527354B (no)
UA (1) UA72890C2 (no)
WO (1) WO2000007987A1 (no)
YU (1) YU8601A (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
TW202317533A (zh) * 2021-07-02 2023-05-01 美商雅斯治療公司 奧沙奈坦(osanetant)之固體形式

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
JP2000515534A (ja) * 1996-08-05 2000-11-21 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ ３，３―二置換ピペリジンの製造方法
US6040316A (en) * 1996-09-16 2000-03-21 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
AU748177B2 (en) 2002-05-30
CN1314888A (zh) 2001-09-26
SK1742001A3 (en) 2001-11-06
DE69908951T2 (de) 2004-05-19
NZ509561A (en) 2002-10-25
DE69908951D1 (de) 2003-07-24
YU8601A (sh) 2003-07-07
KR100571944B1 (ko) 2006-04-18
CA2339007A1 (en) 2000-02-17
CO5070576A1 (es) 2001-08-28
PL345999A1 (en) 2002-01-14
HUP0103134A2 (en) 2002-06-29
CN1114592C (zh) 2003-07-16
EE04274B1 (et) 2004-04-15
WO2000007987A1 (fr) 2000-02-17
ATE243197T1 (de) 2003-07-15
KR20010072220A (ko) 2001-07-31
EA200100096A1 (ru) 2001-08-27
IS5821A (is) 2001-01-23
EP1102747A1 (fr) 2001-05-30
UA72890C2 (en) 2005-05-16
EE200100070A (et) 2002-06-17
FR2782082B3 (fr) 2000-09-22
JP2002522419A (ja) 2002-07-23
BR9913357A (pt) 2001-05-15
PT1102747E (pt) 2003-09-30
TR200100261T2 (tr) 2001-06-21
AU5168599A (en) 2000-02-28
AR019953A1 (es) 2002-03-27
EP1102747B1 (fr) 2003-06-18
HUP0103134A3 (en) 2003-03-28
HK1035535A1 (en) 2001-11-30
EA003205B1 (ru) 2003-02-27
FR2782082A1 (fr) 2000-02-11
NO20010553D0 (no) 2001-02-01
US7041679B2 (en) 2006-05-09
JP3807938B2 (ja) 2006-08-09
DZ3074A1 (fr) 2004-07-20
ES2200535T3 (es) 2004-03-01
MY121447A (en) 2006-01-28
US20040044215A1 (en) 2004-03-04
DK1102747T3 (da) 2003-09-29
TW527354B (en) 2003-04-11
NO320645B1 (no) 2006-01-09

Similar Documents

Publication Publication Date Title
NO20011083L (no) Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH
ID27092A (id) Pembuatan ftalat anhidrida
CY2014027I2 (el) Xρηση διαλκυλο φουμαρικων εστερων
BR9711151A (pt) Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida
ID29021A (id) Komposisi galantamina pelepasan terkontrol
NO20010899L (no) Forbedring av ugunstige apomorfin-effekter
NO20011886D0 (no) Utforminger av fexofenadin
NO20010298D0 (no) Polymorf av et formakum
NO20023072L (no) Syntese av krystallinske silikoaluminofosfater
IT1312203B1 (it) Fusione di strisce
EE200000743A (et) Kristalliline efavirens
DE60107074D1 (de) Kristallin form ii von cabergolin
NO20010553L (no) Krystallinske former av osanetant
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO20003960D0 (no) Salter av paroksetin
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
NO20013857L (no) Krystallinsk form av Eplerenon
NO20006547D0 (no) Salter av paroxetine
ID24327A (id) Produksi senyawa-senyawa avermektin
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
EE200100381A (et) Morfolinobensamiidi uued soolad
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20004583D0 (no) Krystallinsk form av paroxetine
SE9902239D0 (sv) Kornisch bestående av flera delar